Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo-controlled trial. (Q42551686)
Jump to navigation
Jump to search
scientific article published on January 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo-controlled trial. |
scientific article published on January 1997 |
Statements
Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo-controlled trial (English)
Ching CK
Tung AK
Li E
Young J
Hill A
Wong BC
Dent J